February, 2017 | The Wall Street Analyzer - Part 3

Latest News

[ February 12, 2025 ] VSee Health Announces Contract with Top Kidney Care Provider to Add VSee Workflow to Oracle Cerner EHR News Feed
[ February 7, 2025 ] Greenlite Venture Signs Letter of Intent to Acquire TicketBash.com News Feed
[ February 5, 2025 ] NoLimitCoin Expands to Polygon (POL) and Ethereum (ETH) Networks adding to the (BSC) network, Boosting Greenlite Ecosystem. Consumer
[ February 4, 2025 ] Soligenix to Present at BIO CEO & Investor Conference News Feed
[ January 30, 2025 ] Midnight Sun Intersects High-Grade Oxide Copper at Kazhiba Target Market News
[ January 21, 2025 ] Coinbase CEO Brian Armstrong: It’s really the dawn of a new day for crypto Market News
[ January 14, 2025 ] HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma News Feed

No Picture

Hemispherix BioPharma (NYSE: HEB) CEO: Tom Equels

February 7, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Tom Equels […]

No Picture

BioRem Inc. (TSXV: BRM) (OTC:BIRMF) CEO Derek Webb

February 3, 2017 The Wall Street Analyzer Comments Off

Interview with CEO Derek Webb […]

No Picture

Potash Ridge Corp (TSX:PRK) CEO Interview update

February 2, 2017 The Wall Street Analyzer Comments Off

Interview with Guy Bentinck, CEO […]

No Picture

Neurotrope BioScience (OTCQB:NTRP) CEO Interview

February 1, 2017 The Wall Street Analyzer Comments Off

Interview with Susanne Wilke, CEO […]

Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com